Bioscience Bulletin

Federal Legislative Updates Ohio Legislative Updates G2G Blog G2G Bio Bulletin – April 20, 2026 Back to All Posts Updates from Washington Congress: Both chambers reconvened this week. FY 2027…

Federal Legislative Updates Ohio Legislative Updates G2G Blog G2G Bio Bulletin – April 13, 2026 Back to All Posts Updates from Washington Congress: The House and Senate were on recess…

Federal Legislative Updates Ohio Legislative Updates G2G Blog G2G Bio Bulletin – April 7, 2026 Back to All Posts Funding & Other Opportunities New ARPA-H Program: Systematic Targeting Of MicroPlastics…

Federal Legislative Updates Ohio Legislative Updates G2G Blog G2G Bio Bulletin – March 31, 2026 Back to All Posts April 3, 2026 Update The SBIR/STTR Reauthorization Bill (S. 3971) was presented to…

Committee leaders from both parties have taken actions and floated proposals to address healthcare costs and improve access to medicines.

G2G with Women’s Health Advocates (WHA) the Endo & Adeno Coalition, Krampz Wellness and partners organized an Endometriosis & Adenomyosis Capitol Hill Day on March 10 and an accompanying Congressional Briefing on March 9 to advocate for better research and care for patients.

On Tuesday, the Senate Committee on Commerce, Science & Transportation’s Science Subcommittee convened a hearing on applications of AI. Witnesses were affiliated with RadAI, Siemens, Agility Robotics and the Brookings Institution.

G2G’s DC team was on Capitol Hill this week, alongside dozens of advocates and stakeholders from across the country.

The Congressionally Directed Medical Research Programs (CDMRP) has released pre-announcements for the FY 26 Spinal Cord Injury, ALS, Arthritis, Ovarian Cancer, Pancreatic Cancer and Tick-Borne Disease Research Programs.

The Congressionally Directed Medical Research Programs (CDMRP) has released pre-announcements for FY26 Breast Cancer Research Program (BCRP) and Lupus Research Program (LRP)